Frontiers in Immunology (Oct 2022)
Corrigendum: Circulating T cell activation and exhaustion markers are associated with radiation pneumonitis and poor survival in non-small-cell lung cancer
- Janna Berg,
- Janna Berg,
- Janna Berg,
- Ann Rita Halvorsen,
- Ann Rita Halvorsen,
- May-Bente Bengtson,
- Morten Lindberg,
- Bente Halvorsen,
- Bente Halvorsen,
- Pål Aukrust,
- Pål Aukrust,
- Pål Aukrust,
- Åslaug Helland,
- Åslaug Helland,
- Åslaug Helland,
- Thor Ueland,
- Thor Ueland,
- Thor Ueland
Affiliations
- Janna Berg
- Department of Medicine, Vestfold Hospital Trust, Tønsberg, Norway
- Janna Berg
- Department of Cancer Genetics, Institute for Cancer Research, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway
- Janna Berg
- Department of Clinical Medicine, University of Oslo, Oslo, Norway
- Ann Rita Halvorsen
- Department of Clinical Medicine, University of Oslo, Oslo, Norway
- Ann Rita Halvorsen
- Department of Oncology, Oslo University Hospital, Oslo, Norway
- May-Bente Bengtson
- Department of Medicine, Vestfold Hospital Trust, Tønsberg, Norway
- Morten Lindberg
- Department of Medical Biochemistry, Vestfold Hospital Trust, Tønsberg, Norway
- Bente Halvorsen
- Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway
- Bente Halvorsen
- Institute of Clinical Medicine, University of Oslo, Oslo, Norway
- Pål Aukrust
- Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway
- Pål Aukrust
- Institute of Clinical Medicine, University of Oslo, Oslo, Norway
- Pål Aukrust
- Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital Rikshospitalet, Oslo, Norway
- Åslaug Helland
- Department of Cancer Genetics, Institute for Cancer Research, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway
- Åslaug Helland
- Department of Clinical Medicine, University of Oslo, Oslo, Norway
- Åslaug Helland
- Department of Oncology, Oslo University Hospital, Oslo, Norway
- Thor Ueland
- Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway
- Thor Ueland
- Institute of Clinical Medicine, University of Oslo, Oslo, Norway
- Thor Ueland
- K.G. Jebsen Thrombosis Research and Expertise Center, University of Tromsø, Tromsø, Norway
- DOI
- https://doi.org/10.3389/fimmu.2022.1051156
- Journal volume & issue
-
Vol. 13
Abstract
No abstracts available.Keywords
- lung cancer
- radiotherapy
- stereotactic body radiation therapy
- radiation pneumonitis
- radiation-induced lung injury (RILI)
- blood biomarkers